公开(公告)号：EP3174580A4

公开(公告)日：2018-04-04

申请号：EP15827601

申请日：2015-07-31

申请人： HOSPIRA INC

发明人： SUNDQUIST JOHN ,  RUSH BEN ,  BROWKA EDWARD PAUL ,  FOSHEE DAVID L ,  WILLARD GRETCHEN E ,  MYERS STEPHEN ,  RODRIGUEZ HECTOR ,  HORTON JOHN COLEMAN

IPC分类号： A61M5/315 ,  A61M5/24 ,  A61M5/50

CPC分类号： A61M5/31515 ,  A61M5/31501 ,  A61M5/31505 ,  A61M5/31513 ,  A61M5/347 ,  A61M5/50 ,  A61M5/502 ,  A61M5/508 ,  A61M5/5086 ,  A61M2005/206 ,  A61M2005/2073 ,  A61M2005/2407 ,  A61M2005/247 ,  A61M2005/312 ,  A61M2005/3238 ,  A61M2005/5073

摘要： Methods and systems for an injection system are provided. An example injection system includes a container for a pharmaceutical that is sealed at a proximal end with a plunger having a pushing surface for engaging an inner surface of the hollow body. A plunger rod extends axially from the proximal end of the container and is covered with a plunger rod cover. Removal of the cover activates the system and allows for delivery of the pharmaceutical product from the container by advancing the plunger within the container towards the seal.

公开(公告)号：EP2734212B1

公开(公告)日：2017-09-06

申请号：EP12814382.3

申请日：2012-07-19

申请人： Hospira, Inc.

发明人： LACOUTURE, Peter ,  GARCIA DE ROCHA, Marcelo ,  CARR, Daniel, B.

IPC分类号： A61K31/196 ,  A61K31/724 ,  A61K9/00 ,  A61K9/08 ,  A61K47/40 ,  A61P25/00 ,  A61P43/00

CPC分类号： A61K47/40 ,  A61K9/0019 ,  A61K9/08 ,  A61K31/196

公开(公告)号：EP3154609A1

公开(公告)日：2017-04-19

申请号：EP15809382.3

申请日：2015-06-16

申请人： Hospira, Inc.

发明人： DAY, WIlliam ,  RUCHTI, Timothy

IPC分类号： A61M5/172

CPC分类号： A61M5/1723 ,  A61M5/365 ,  A61M2005/14208 ,  A61M2005/16863 ,  A61M2205/16 ,  A61M2205/18 ,  A61M2205/3553 ,  G06F19/00 ,  G16H20/10 ,  G16H20/17

摘要： A system and method for monitoring and delivering medication to a patient. The system includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule based application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. A system monitor is also in communication with the controller to monitor system, remote system, and network activity and conditions. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.

摘要翻译： 一种用于监视和提供药物给病人的系统和方法。 该系统包括一个控制器做具有控制算法和闭环控制监视器所做的控制算法。 传感器与所述控制器进行通信并监测医学状况。 在控制器的一个基于规则的应用从所述传感器和所述闭环控制接收数据并将数据与预定的医疗信息疗法的自动化的风险进行比较，以确定矿给患者。 因此，一个系统监视器是与控制器以监视系统，远程系统和网络活动和条件的通信。 然后，控制器提供的下方设置所述预定风险阈值自动闭环药物治疗，其中的预定风险阈值。 如果预定的风险阈值达到或超过，自动调整治疗可能不会发生，并要求用户/临床医生的干预。

公开(公告)号：EP2964079A1

公开(公告)日：2016-01-13

申请号：EP14760652.9

申请日：2014-03-06

申请人： Hospira, Inc.

发明人： JHA, Prakash, K. ,  CUDNEY, James ,  HERR, Benjamin ,  LEE, Mark, I. ,  PICINICH, Matteo, D.

IPC分类号： A61B5/00

CPC分类号： H04L45/74 ,  G06F19/00 ,  G06F19/3418 ,  H04L45/302 ,  H04L69/16 ,  H04L69/162 ,  H04L69/165 ,  H04L69/32

摘要： A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

摘要翻译： 可以在各种医疗设备（包括但不限于输液泵）内实施的医疗设备通信方法。 该方法可以用用于至少设备内通信的协议栈来实现。 实施例提供面向连接，面向无连接的广播和多播数据交换，其具有数据的优先处理，数据的分段和重组，独立的静态和动态地址分配以及用于连接的外围设备或子系统的热插拔能力。

公开(公告)号：EP2419009A4

公开(公告)日：2015-07-29

申请号：EP10765238

申请日：2010-04-16

申请人： HOSPIRA INC

发明人： WEHBA STEVEN R ,  RUCHTI TIMOTHY L

IPC分类号： A61B5/00

CPC分类号： A61M5/1723 ,  A61M2005/1405 ,  A61M2005/14208 ,  A61M2005/14296 ,  A61M2205/18 ,  A61M2205/3553 ,  A61M2205/3561 ,  A61M2205/50 ,  A61M2205/52 ,  A61M2230/04 ,  A61M2230/06 ,  A61M2230/201 ,  A61M2230/202 ,  A61M2230/205 ,  A61M2230/30 ,  A61M2230/42 ,  A61M2230/50 ,  G06F19/327 ,  G06F19/345 ,  G06F19/3468 ,  G16H40/20 ,  G16H50/20

摘要： A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.

公开(公告)号：EP2744533A4

公开(公告)日：2015-07-15

申请号：EP12825020

申请日：2012-08-17

申请人： HOSPIRA INC

发明人： SUR KUNAL ,  KOTNIK PAUL T ,  BELKIN ANATOLY S ,  DUMAS III JOHN HICKS ,  RUCHTI TIMOTHY L

IPC分类号： A61M1/00 ,  A61M5/142 ,  A61M5/36

CPC分类号： A61M5/365 ,  A61M5/142 ,  A61M2205/18 ,  A61M2205/50

摘要： An infusion system includes a pump, a fluid delivery line, a sensor, a processor, and a memory. The fluid delivery line is connected to the pump for delivering fluid. The sensor is connected to the fluid delivery line for emitting and receiving signals to detect whether there is air in the fluid delivery line. The processor is in electronic communication with the pump and the sensor. The memory is in electronic communication with the processor. The memory includes programming code for execution by the processor. The programming code is configured to analyze the signals to determine if a stuck fluid droplet is stuck within the fluid delivery line at a location of the sensor.

公开(公告)号：EP2719386A1

公开(公告)日：2014-04-16

申请号：EP14150954.7

申请日：2009-07-29

申请人： The Medicines Company ,  Hospira, Inc.

发明人： Motheram, Rajeshwar ,  Krishna, Gopal ,  Ding, Min ,  Flood, Keith ,  Ramakrishna, Kornepati

IPC分类号： A61K31/519 ,  A61P9/12

CPC分类号： A61K31/4422 ,  A61K31/519 ,  G01N30/02

摘要： A pharmaceutical composition is provided which comprises clevidipine as an active ingredient and has a level of the degradants Substance 23, Substance 24 and Substance 25 that is approximately equal to or no more than 0.2% on a weight-by-weight of impurity basis to clevidipine and an amount of the impurity H168/79 that is no greater than about 1.5%.

摘要翻译： 本发明提供一种药物组合物，其包含氯维地平作为活性成分，并具有降解物质23，物质24和物质25做的电平大约等于或不大于0.2％按重量计重杂质基础氯维地平的 并且在杂质H168 / 79所做的量是不大于约1.5％以上。

公开(公告)号：EP2278913A4

公开(公告)日：2013-11-20

申请号：EP09743631

申请日：2009-05-07

申请人： HOSPIRA INC

发明人： LOWERY MICHAEL G ,  FATHALLAH MARWAN A ,  ZIEGLER JOHN S ,  BRUMUND RYAN ,  BARCLAY BRIAN ,  WALSWORTH FRANK ,  JACOBSON JAMES D ,  MOY YEI FENG ,  JOHNSON THOMAS D

IPC分类号： A61B5/00 ,  A61B5/145 ,  A61M39/10

CPC分类号： A61B5/14532 ,  A61B5/145 ,  A61B5/1486 ,  A61B5/15003 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150358 ,  A61B5/150389 ,  A61B5/150503 ,  A61B5/15087 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/155 ,  A61B5/157 ,  A61M5/14228

摘要： A point of care fluid testing system for determining properties of a fluid comprises a patient connection, a primary fluid routing portion, a pump, a secondary fluid routing portion, and a flushing fluid connection. The patient connection connects the system to a patient. The primary fluid routing portion has a pump region, a fluid transfer region, and an in-line testing region. The pump region pumps the fluid sample from the patient to the testing portion and back to the patient. The in-line testing region evaluates a first characteristic of the fluid sample. The fluid transfer region transmits a portion of the fluid sample out of the primary fluid routing portion. The secondary fluid routing portion includes an off-line testing portion that receives the portion of the fluid sample transmitted from the fluid transfer region. The off-line testing portion evaluates a second characteristic of the fluid sample.

公开(公告)号：EP2655885A1

公开(公告)日：2013-10-30

申请号：EP11851186.4

申请日：2011-12-22

申请人： Hospira, Inc.

发明人： MOY, Yei F. ,  ZIEGLER, John S.

IPC分类号： F04B43/08 ,  F04B43/12

CPC分类号： F04B43/08 ,  F04B43/12

摘要： A medical pump includes a chassis having a fixed seat and a carriage having a footing for receiving a fluid delivery device and restricting its movement. An actuator assembly is provided that allows for moving the carriage between an opened and closed position to engage the fluid delivery device to the seat. A rack and pinion system is utilized in combination with a cam element and spring element to provide a bi-stable actuator assembly that urges the carriage into a fully opened position or a fully closed position and will not allow the carriage to dwell in an intermediate position if external force is withdrawn.

公开(公告)号：EP2223279A4

公开(公告)日：2013-10-16

申请号：EP08847611

申请日：2008-11-06

申请人： HOSPIRA INC

发明人： WEHBA STEVEN R ,  RINDA JEFFREY E ,  WARD PATRICK

IPC分类号： G06F19/00 ,  G06Q10/00

CPC分类号： G06Q10/00 ,  G06F19/326 ,  G06F19/3456 ,  G06Q50/22 ,  G06Q50/24 ,  G16H40/40 ,  G16H40/63

摘要： A method and system for synchronizing medication configuration information. A primary medication configuration computer is adapted to receive medication configuration content from a medication configuration content source. The primary medication configuration computer is also adapted to generate medication configuration change information and transmit the medication configuration change information to an ancillary medication configuration computer, adapted to receive the medication configuration change information from the primary medication configuration computer. The ancillary medication configuration computer is also adapted to filter the medication configuration change information by applying a filtering rule to generate filtered medication configuration change information. The ancillary medication configuration computer is further adapted to store the filtered medication configuration change information in a repository and transmit at least a portion of the filtered medication configuration change information to a management client computer. The ancillary medication configuration computer is also adapted to receive an implementation decision about the portion of the filtered medication configuration change information, accepting or rejecting the portion of the filtered medication configuration change information. The ancillary medication configuration computer is also adapted to transmitting the accepted filtered medication configuration change information to an ancillary system database for integrating the accepted filtered medication configuration change information into the ancillary system database.